View in EDS

Pharmacokinetics and safety of apremilast in pediatric patients with moderate to severe plaque psoriasis: Results from a phase 2 open-label study.

Saved in:
Bibliographic Details
Title: Pharmacokinetics and safety of apremilast in pediatric patients with moderate to severe plaque psoriasis: Results from a phase 2 open-label study.
Authors: Paller AS; Northwestern University Feinberg Medical School, Chicago, Illinois. Electronic address: apaller@northwestern.edu., Hong Y; Celgene Corporation, Summit, New Jersey., Becker EM; University of Texas Health Science Center-San Antonio, San Antonio, Texas., de Lucas R; Hospital Universitario La Paz, Madrid, Spain., Paris M; Celgene Corporation, Summit, New Jersey., Zhang W; Celgene Corporation, Summit, New Jersey., Zhang Z; Celgene Corporation, Summit, New Jersey., Barcellona C; Celgene Corporation, Summit, New Jersey., Maes P; Celgene Corporation, Summit, New Jersey., Fiorillo L; Pediatric Department, University of Alberta, Edmonton, Canada.
Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2020 Feb; Vol. 82 (2), pp. 389-397. Date of Electronic Publication: 2019 Aug 10.
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
Journal Info: Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787 (Electronic) Linking ISSN: 01909622 NLM ISO Abbreviation: J Am Acad Dermatol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 31408686
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Pharmacokinetics and safety of apremilast in pediatric patients with moderate to severe plaque psoriasis: Results from a phase 2 open-label study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Paller+AS%22">Paller AS</searchLink>; Northwestern University Feinberg Medical School, Chicago, Illinois. Electronic address: apaller@northwestern.edu.<br /><searchLink fieldCode="AU" term="%22Hong+Y%22">Hong Y</searchLink>; Celgene Corporation, Summit, New Jersey.<br /><searchLink fieldCode="AU" term="%22Becker+EM%22">Becker EM</searchLink>; University of Texas Health Science Center-San Antonio, San Antonio, Texas.<br /><searchLink fieldCode="AU" term="%22de+Lucas+R%22">de Lucas R</searchLink>; Hospital Universitario La Paz, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Paris+M%22">Paris M</searchLink>; Celgene Corporation, Summit, New Jersey.<br /><searchLink fieldCode="AU" term="%22Zhang+W%22">Zhang W</searchLink>; Celgene Corporation, Summit, New Jersey.<br /><searchLink fieldCode="AU" term="%22Zhang+Z%22">Zhang Z</searchLink>; Celgene Corporation, Summit, New Jersey.<br /><searchLink fieldCode="AU" term="%22Barcellona+C%22">Barcellona C</searchLink>; Celgene Corporation, Summit, New Jersey.<br /><searchLink fieldCode="AU" term="%22Maes+P%22">Maes P</searchLink>; Celgene Corporation, Summit, New Jersey.<br /><searchLink fieldCode="AU" term="%22Fiorillo+L%22">Fiorillo L</searchLink>; Pediatric Department, University of Alberta, Edmonton, Canada.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227907132%22">Journal of the American Academy of Dermatology</searchLink> [J Am Acad Dermatol] 2020 Feb; Vol. 82 (2), pp. 389-397. <i>Date of Electronic Publication: </i>2019 Aug 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Mosby%22">Mosby </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7907132 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-6787 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201909622%22">01909622 </searchLink><i>NLM ISO Abbreviation: </i>J Am Acad Dermatol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31408686
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jaad.2019.08.019
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 389
    Titles:
      – TitleFull: Pharmacokinetics and safety of apremilast in pediatric patients with moderate to severe plaque psoriasis: Results from a phase 2 open-label study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Paller AS
      – PersonEntity:
          Name:
            NameFull: Hong Y
      – PersonEntity:
          Name:
            NameFull: Becker EM
      – PersonEntity:
          Name:
            NameFull: de Lucas R
      – PersonEntity:
          Name:
            NameFull: Paris M
      – PersonEntity:
          Name:
            NameFull: Zhang W
      – PersonEntity:
          Name:
            NameFull: Zhang Z
      – PersonEntity:
          Name:
            NameFull: Barcellona C
      – PersonEntity:
          Name:
            NameFull: Maes P
      – PersonEntity:
          Name:
            NameFull: Fiorillo L
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2020 Feb
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1097-6787
          Numbering:
            – Type: volume
              Value: 82
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Journal of the American Academy of Dermatology
              Type: main
ResultId 1